Rapid Response to Trametinib Combined With Chemotherapy for Infant BRAF‐Fused Chiasmatic Glioma
Pediatric Blood & Cancer · 2026-06 · 73 (6)
DOI: 10.1002/1545-5017.70258 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 17.03.2026. Verfasst von Helen Toledano und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology-Oncology, Schneider Children's Medical Center of Israel, Petah Tikva, Israel. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Glioma, Oncogene Proteins, Fusion, Optic Chiasm. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Infants, less than 1 year, with chiasmatic gliomas (ICG) present a major therapeutic challenge due to large tumor size, decreased vision, rapid progression, and poor response to vincristine/carboplatin chemotherapy. The majority have a BRAF fusion, which may respond to downstream MEK inhibitors but response time is slow. There are no safety or efficacy data for MEK inhibitors in infants or in combination with chemotherapy. We report two infants with BRAF‐fused ICG presenting at age 5 months with nystagmus and diencephalic syndrome. Significant tumor progression occurred after only 6 weeks on chemotherapy and showed dramatic response to the addition of trametinib.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Hematology-Oncology, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
- Gray Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Department of Radiology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
- Department of Radiology, Rabin Medical Center, Petach Tikva, Israel.
- Pediatric Dermatology Unit, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
- Department of Ophthalmology, Ophthalmology Unit, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
Zitieren
APA
Toledano, H., Yelak, A., Kaadan, W., Caduri, S., Friedland, R., Michaeli, O., Dotan, G., & Konen, O. (2026). Rapid Response to Trametinib Combined With Chemotherapy for Infant BRAF‐Fused Chiasmatic Glioma. Pediatric Blood & Cancer, 73(6). https://doi.org/10.1002/1545-5017.70258
Vancouver
Toledano H, Yelak A, Kaadan W, Caduri S, Friedland R, Michaeli O, et al. Rapid Response to Trametinib Combined With Chemotherapy for Infant BRAF‐Fused Chiasmatic Glioma. Pediatric Blood & Cancer. 2026;73(6). doi:10.1002/1545-5017.70258
BibTeX
@article{Toledano2026,
author = {Toledano, Helen and Yelak, Alexander and Kaadan, Walid and Caduri, Shlomo and Friedland, Rivka and Michaeli, Orli and Dotan, Gad and Konen, Osnat},
title = {Rapid Response to Trametinib Combined With Chemotherapy for Infant BRAF‐Fused Chiasmatic Glioma},
journal = {Pediatric Blood & Cancer},
year = {2026},
volume = {73},
number = {6},
doi = {10.1002/1545-5017.70258}
}
EUVIMED